Aquatic High-Intensity Interval Training Aids Exercise Capacity for Chronic Conditions
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 22, 2023 -- Aquatic high-intensity interval training (AHIIT) improves exercise capacity in people with a range of chronic conditions, according to a review published online Nov. 14 in BMJ Open Sport & Exercise Medicine.
Heidi Bunæs-Næss, from Oslo Metropolitan University in Norway, and colleagues conducted a systematic literature review to investigate the effect of AHIIT on exercise capacity in people with chronic conditions (musculoskeletal, respiratory, cardiovascular, metabolic, or neurological).
Based on 18 included studies (868 participants), the researchers found moderate certainty in evidence according to the Grading of Recommendations Assessment, Development and Evaluation system for a moderate beneficial effect of AHIIT on exercise capacity (standardized mean differences [SMD], 0.78; 95 percent confidence interval [CI], 0.48 to 1.08; P < 0.00001) versus a nonexercising control group. Compared with land-based HIIT, there was moderate certainty in evidence for no difference of effects on exercise capacity (SMD, 0.28; 95 percent CI, −0.04 to 0.60; P = 0.08) with AHIIT. Compared with aquatic moderate-intensity continuous training, AHIIT had moderate certainty in evidence for a small effect on exercise capacity (SMD, 0.45; 95 percent CI, 0.10 to 0.80; P = 0.01).
"Aquatic HIIT may increase adherence to exercise training and should be considered as an exercise option," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.